Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
108,074,661
-
Total 13F shares
-
23,711,078
-
Share change
-
+2,390,546
-
Total reported value
-
$707,195,746
-
Price per share
-
$29.82
-
Number of holders
-
111
-
Value change
-
+$74,703,828
-
Number of buys
-
70
-
Number of sells
-
48
Institutional Holders of Aclaris Therapeutics, Inc. - Common Stock (ACRS) as of Q1 2017
As of 31 Mar 2017,
Aclaris Therapeutics, Inc. - Common Stock (ACRS) was held by
111 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,711,078 shares.
The largest 10 holders included
Vivo Capital, LLC, FMR LLC, Sofinnova Management VIII, L.L.C., PERCEPTIVE ADVISORS LLC, FRANKLIN RESOURCES INC, PointState Capital LP, Polar Capital LLP, Cormorant Asset Management, LLC, BlackRock Inc., and VANGUARD GROUP INC.
This page lists
111
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.